PMDD: An Honest Overview of Premenstrual Dysphoric Disorder

Premenstrual dysphoric disorder is a recognised condition, and it is diagnosed by a clinician rather than by a list. The NHS names it as a severe form of premenstrual syndrome whose symptoms are much more intense and can have a much greater negative impact on everyday life; ACOG describes it as a severe form of PMS that interferes with a woman's daily life; and its diagnostic criteria are set out in the DSM-5, the American Psychiatric Association's manual. Those criteria require at least five of eleven symptoms, a specific timing across the cycle, most cycles of the previous year, and confirmation with at least two cycles of daily ratings recorded as they happen. No web page can apply them to you, and this one will not try.

What PMDD is

It is a condition. Not a mood, not a personality, not a bad week that needs better organising, and not something a page like this one should be handing lifestyle advice about.

The NHS describes it as more severe symptoms of PMS, similar in kind but much more intense, with a much greater negative impact on everyday life. ACOG's version is that if premenstrual symptoms are severe and cause problems with work or personal relationships, that may be PMDD — which it describes as a severe form of PMS that interferes with a woman's daily life and affects a small percentage of women. The symptoms ACOG names include sharp mood swings, irritability, hopelessness, anxiety, problems concentrating, changes in appetite, sleep problems and bloating.

What causes it is not settled. The NHS says it is not clear, and that it has been linked to being very sensitive to changes in hormones, or to certain inherited differences in genes. Sensitivity to a change is not the same as an abnormal level of anything, which is one reason PMDD is not a thing a blood test finds.

The timing is what separates it from a mood disorder that happens to be bad this month, and the timing is also what makes it possible to establish — which brings us to how it is actually done.

How it is diagnosed, and by whom

The DSM-5 criteria have a specific shape. A woman must experience at least five of eleven symptoms, at least one of them a key mood symptom. Those symptoms must be present in the final week of the luteal phase, remit within a few days after the period starts, and become minimal or absent in the week afterwards. The pattern must have occurred in most cycles in the previous year. And it must be confirmed with at least two cycles of prospective daily ratings — ratings made day by day as the cycles happen, not remembered afterwards.

Now the part that matters more than the list. The same paper that sets out those criteria says a daily rating tool is a tool and does not negate the need for clinical assessment: the provider should make the final judgment. That is not a formality. Reading five symptoms and recognising yourself is not a diagnosis, however exactly the description fits, and a page that implied otherwise would be doing the thing this site was built to refuse.

The route is a GP or another clinician, with a record in your hand. The record is what makes that appointment work, because the criteria are about timing and nobody can reconstruct two months of timing from memory.

How common it is, and why the numbers disagree so wildly

A 2025 cross-sectional study of 45,160 women aged 20 to 49, across 303 clinics in Brazil, put the prevalence of PMDD at 3.57%, with a 95% confidence interval of 3.40 to 3.75. Its authors are careful about what that number is: the symptoms were self-reported using a screening method with high sensitivity but low specificity, and the lack of a clinical diagnosis may have allowed the inclusion of women whose symptoms had other medical causes.

Set that against the wider literature and the picture gets stranger. A 2023 review reports that the prevalence of PMDD ranges from 2.1% to 79.9% depending on the assessment tools used — a spread so wide it is not really an estimate of anything — narrowing to 2.9% to 4.1% in clinical populations.

That gap is the story of this page in one line. The high figures come from asking people to look back and report; the low ones come from clinical assessment. The review states why: retrospective reporting is more prone to false positives and overdiagnosis. It also notes that accurate assessment and diagnosis require rigorous training of midwives, nurses and primary care physicians — the skill is in the assessing, not in the questionnaire.

So when a page says "up to X% of women have PMDD", the number is usually telling you which instrument was used rather than how common the condition is. The honest range from clinical populations is somewhere near 3 to 4 in 100.

Treatment is a conversation with a doctor

Two things can be said here, both attributed, and nothing else.

ACOG states that selective serotonin reuptake inhibitors can help treat PMDD in some women. The NHS says it is not clear what causes PMDD, and links it to hormone sensitivity or inherited genetic differences.

That is the whole of what this page will say about treatment. No dose, no first choice, no ranking, no "natural alternative", and no suggestion that any of it can be started without a prescription and a conversation. Which treatment fits depends on your history, on what else is going on, and on things a clinician asks about and a web page never sees. If you take one thing from this section, take the fact that there is something to treat and a route to it — which is a better reason to make the appointment than a symptom list is.

What a daily record can do, and what it cannot

The criteria ask for at least two cycles of daily ratings, and that standard is not unique to the DSM-5. The International Society for Premenstrual Disorders recommends that a diagnosis is confirmed only after reviewing data recorded across two consecutive menstrual cycles, because the retrospective assessment of symptoms has limited value and requires validation against an established prospective technique. Two independent routes to the same instruction: write it down as it happens. That is the single most useful thing you can arrive with, and it is the honest reason this page points at paper.

A printable symptom tracker gives you a row per symptom and a box per day; the printable period tracker keeps the start dates the timing is measured against. Fill either one in on the day, including the days when nothing is wrong — the blank days are the evidence for "minimal or absent in the week afterwards", so they are not wasted entries. If you would rather see where you are in the cycle while you do it, the cycle phase calculator places you from two dates and shows the edges as bands, because that is what arithmetic on two dates can honestly produce.

What none of that is: a screening instrument. This site does not offer one and is not trying to approximate one. A printable grid does not score you, does not decide anything, and cannot tell you whether what you have is PMDD. It records. The reading happens in the appointment, where a clinician does the assessing — which the research on this condition is emphatic about, since the difference between a 3.57% prevalence and a 79.9% one is mostly the difference between assessment and a questionnaire.

PMDD, PMS, and the difference that is not just volume

It is tempting to file PMDD as "PMS, but worse", and both the NHS and ACOG do describe it as a severe form. The reason to be careful with that shorthand is what it does to the reader: severity language makes it sound like a matter of degree, as though the answer were to cope harder. The criteria are not written that way. They ask for a specific number of specific symptoms, in a specific week, remitting on a specific schedule, across most of a year — a defined condition with a defined shape, which is exactly what makes it treatable rather than a character flaw.

What ordinary premenstrual symptoms look like, why a symptom list is nearly useless without dates, and the fact that about half of women seeking treatment for PMS turn out to have depression or an anxiety disorder whose symptoms run all month, are all in what the evidence says about PMS. The stretch of the cycle these criteria are anchored to is described in the luteal phase. And the sleep half of it — reported as poor, not always visible in a laboratory, and real either way — is in your cycle and sleep.

If the week before your period is doing damage to your life, that is a reason to book an appointment, not a reason to keep reading. Take two cycles of daily entries with you. The provider makes the judgment; the record is what you bring.